University of Leipzig: Myocardial Infarction trials

The registry lists 13 Myocardial Infarction studies with University of Leipzig as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 2 1Phase 3 3Phase 4 4No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Effect of Conditioning on Myocardial Damage in STEMICompletedNCT02158468Not applicable
• Mild Hypothermia in Cardiogenic Shock Complicating Myocardial InfarctionCompletedNCT01890317Not applicable
• Thrombus Aspiration in ThrOmbus Containing culpRiT Lesions in Non-ST-Elevation Myocardial Infarction (TATORT-NSTEMI)CompletedNCT01612312Phase 4
• Effect of Thrombus Aspiration in Patients With Myocardial Infarction Presenting Late After Symptom OnsetCompletedNCT01379248Phase 4
• Right Ventricular Damage in Cardiovascular Magnetic ResonanceCompletedNCT01359306
• ImmeDiate Versus EArLy Invasive Approach in Non-ST-Elevation Myocardial Infarction (IDEAL NSTEMI)WithdrawnNCT00954668Not applicable
• Myocardial Salvage Assessed by Cardiovascular Magnetic Resonance - Impact on OutcomeCompletedNCT00952224
• Reproducibility of Magnetic Resonance Myocardial Salvage IndexCompletedNCT00794300
• Abciximab i.v. Versus i.c. in ST-elevation Myocardial InfarctionCompletedNCT00712101Phase 3
• Intraaortic Balloon Pump in Cardiogenic Shock IICompletedNCT00491036Phase 4
• Myocardial Salvage and Contrast Dye Induced Nephropathy Reduction by N-AcetylcysteinCompletedNCT00463749Phase 3
• Randomized Trial of Immediate Versus Early and Selective Invasive Percutaneous Coronary Intervention in NSTEMICompletedNCT00402675Phase 4
• Abciximab i.v. Versus i.c. in Primary PCI Patients With STEMICompletedNCT00299377Phase 2/3